Emily Lavinder
About Emily Lavinder
Emily Lavinder serves as the Associate Director of Clinical Programming at Aimmune Therapeutics, bringing extensive experience in SAS data programming from her previous roles at Novella Clinical and Salix Pharmaceuticals.
Current Role at Aimmune Therapeutics
Emily Lavinder serves as the Associate Director of Clinical Programming at Aimmune Therapeutics. She has held this position since 2020, contributing to the company's clinical programming efforts in Durham, North Carolina. In this role, she oversees programming activities and ensures compliance with regulatory standards.
Previous Experience in Clinical Programming
Prior to her current role, Lavinder worked at Aimmune Therapeutics as the Senior Manager of Statistical Programming from 2018 to 2020. She also has extensive experience at Novella Clinical, where she held multiple positions, including Associate Manager, SAS Data Programming, and Manager, SAS Data Programming, from 2016 to 2018. Her roles involved managing programming teams and developing statistical analysis plans.
Background in Pharmaceutical Programming
Emily Lavinder has a solid background in pharmaceutical programming, having worked at Salix Pharmaceuticals as a SAS Programmer from 2013 to 2015 and as a Contract SAS Programmer from 2012 to 2013. Her experience in these roles involved data analysis and programming for clinical trials, enhancing her expertise in the field.
Early Career and Education
Lavinder began her career as an Operations Analyst at Credit Suisse, where she worked from 2006 to 2007. She later transitioned to programming roles in the pharmaceutical industry. She holds a Bachelor of Science degree in Mathematics Decision Science from Averett University, which she completed from 2001 to 2003.